Literature DB >> 24105451

Orexinergic activity modulates altered vital signs and pituitary hormone secretion in experimental sepsis.

Clifford S Deutschman1, Nichelle R Raj, Erin O McGuire, Max B Kelz.   

Abstract

OBJECTIVES: Sepsis is a common, lethal poorly understood disorder affecting nearly a million Americans annually. The syndrome is characterized by altered cardiodynamics, respiration, metabolism, pituitary function, arousal, and impaired interaction among organ systems. The immunologic and endocrine systems, which are in part responsible for organ-organ communication, have been studied extensively in sepsis. However, little is known about sepsis-induced changes in central nervous system activity. HYPOTHESIS: A defect in hypothalamic neurons secreting the neurotransmitter orexin modulates physiologic derangements in sepsis.
DESIGN: Animal study.
SETTING: University Research Laboratory.
INTERVENTIONS: Male C57Bl6 mice were made septic using cecal ligation and puncture. Data were collected 24 or 48 hours later, blood was collected, animals were killed, and brain tissue was harvested, fixed, and sectioned. Hypothalamic sections were subjected to immunohistochemistry using antibodies to orexin and c-Fos, a marker of neuronal activity. In a separate cohort of mice, cannulas were placed in the right lateral cerebral ventricle. Cecal ligation and puncture was performed 1 week later. At 24 or 48 hours post-cecal ligation and puncture, vital signs were measured, and1 µL of saline with or without 3 nmol orexin-A was infused. Vital signs were repeated at 25 or 49 hours post-cecal ligation and puncture, blood was collected, animals were killed, and brains were removed, fixed, sectioned, and stained.
MEASUREMENTS AND MAIN RESULTS: Orexinergic activity decreased six-fold following cecal ligation and puncture. This change was associated with decreases in arousal, temperature, and heart and respiratory rates. Levels of selected pituitary hormones increased 24 hours post-cecal ligation and puncture but were significantly lower than baseline at 48 hours. Injection of orexin-A increased vital signs to baseline levels. Hormone levels were unaffected at 25 hours but increased to supranormal levels at 49 hours.
CONCLUSIONS: Sepsis-induced changes in activity, vital signs, and pituitary hormones are modulated by the orexinergic system. This finding implicates central nervous system dysfunction in the pathogenesis of sepsis, suggesting further study of neurological dysfunction to identify novel approaches to management.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24105451      PMCID: PMC6880745          DOI: 10.1097/CCM.0b013e31828e9843

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  41 in total

1.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

2.  Long-term cognitive impairment and functional disability among survivors of severe sepsis.

Authors:  Theodore J Iwashyna; E Wesley Ely; Dylan M Smith; Kenneth M Langa
Journal:  JAMA       Date:  2010-10-27       Impact factor: 56.272

3.  Stimulation of cortical acetylcholine release by orexin A.

Authors:  J Fadel; R Pasumarthi; L R Reznikov
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

4.  HMGB1 mediates cognitive impairment in sepsis survivors.

Authors:  Sangeeta S Chavan; Patricio T Huerta; Sergio Robbiati; S I Valdes-Ferrer; Mahendar Ochani; Meghan Dancho; Maya Frankfurt; Bruce T Volpe; Kevin J Tracey; Betty Diamond
Journal:  Mol Med       Date:  2012-09-07       Impact factor: 6.354

Review 5.  Long-term mortality and quality of life in sepsis: a systematic review.

Authors:  Bradford D Winters; Michael Eberlein; Janice Leung; Dale M Needham; Peter J Pronovost; Jonathan E Sevransky
Journal:  Crit Care Med       Date:  2010-05       Impact factor: 7.598

6.  Orexin neurons are indispensable for stress-induced thermogenesis in mice.

Authors:  Wei Zhang; Jinko Sunanaga; Yoshiko Takahashi; Taketsugu Mori; Takeshi Sakurai; Yuichi Kanmura; Tomoyuki Kuwaki
Journal:  J Physiol       Date:  2010-08-31       Impact factor: 5.182

7.  Lipopolysaccharide challenge-induced suppression of Fos in hypothalamic orexin neurons: their potential role in sickness behavior.

Authors:  Ronald P A Gaykema; Lisa E Goehler
Journal:  Brain Behav Immun       Date:  2009-03-27       Impact factor: 7.217

8.  Orexin neurons in the hypothalamus mediate cardiorespiratory responses induced by disinhibition of the amygdala and bed nucleus of the stria terminalis.

Authors:  Wei Zhang; Na Zhang; Takeshi Sakurai; Tomoyuki Kuwaki
Journal:  Brain Res       Date:  2009-01-27       Impact factor: 3.252

9.  Halothane-induced hypnosis is not accompanied by inactivation of orexinergic output in rodents.

Authors:  Heinrich Gompf; Jingqiu Chen; Yi Sun; Masashi Yanagisawa; Gary Aston-Jones; Max B Kelz
Journal:  Anesthesiology       Date:  2009-11       Impact factor: 7.892

10.  Caffeine restores myocardial cytochrome oxidase activity and improves cardiac function during sepsis.

Authors:  Richa Verma; Zhishan Huang; Clifford S Deutschman; Richard J Levy
Journal:  Crit Care Med       Date:  2009-04       Impact factor: 7.598

View more
  17 in total

1.  Sepsis Pathophysiology, Chronic Critical Illness, and Persistent Inflammation-Immunosuppression and Catabolism Syndrome.

Authors:  Juan C Mira; Lori F Gentile; Brittany J Mathias; Philip A Efron; Scott C Brakenridge; Alicia M Mohr; Frederick A Moore; Lyle L Moldawer
Journal:  Crit Care Med       Date:  2017-02       Impact factor: 7.598

2.  Translational Research: The Model Matters.

Authors:  Clifford S Deutschman
Journal:  Crit Care Med       Date:  2018-05       Impact factor: 7.598

Review 3.  Understanding the HPA response to critical illness: novel insights with clinical implications.

Authors:  Eva Boonen; Greet Van den Berghe
Journal:  Intensive Care Med       Date:  2014-11-19       Impact factor: 17.440

4.  Reduced nocturnal ACTH-driven cortisol secretion during critical illness.

Authors:  Eva Boonen; Philippe Meersseman; Hilke Vervenne; Geert Meyfroidt; Fabian Guïza; Pieter J Wouters; Johannes D Veldhuis; Greet Van den Berghe
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-02-25       Impact factor: 4.310

5.  Use of Organ Dysfunction as a Primary Outcome Variable Following Cecal Ligation and Puncture: Recommendations for Future Studies.

Authors:  Mabel N Abraham; Alexander P Kelly; Ariel B Brandwein; Tiago D Fernandes; Daniel E Leisman; Matthew D Taylor; Mariana R Brewer; Christine A Capone; Clifford S Deutschman
Journal:  Shock       Date:  2020-08       Impact factor: 3.454

Review 6.  Molecular and Functional Neuroscience in Immunity.

Authors:  Valentin A Pavlov; Sangeeta S Chavan; Kevin J Tracey
Journal:  Annu Rev Immunol       Date:  2018-04-26       Impact factor: 28.527

Review 7.  Inflammation-sleep interface in brain disease: TNF, insulin, orexin.

Authors:  Ian A Clark; Bryce Vissel
Journal:  J Neuroinflammation       Date:  2014-03-21       Impact factor: 8.322

8.  Peripherally administered orexin improves survival of mice with endotoxin shock.

Authors:  Yasuhiro Ogawa; Yoko Irukayama-Tomobe; Nobuyuki Murakoshi; Maiko Kiyama; Yui Ishikawa; Naoto Hosokawa; Hiromu Tominaga; Shuntaro Uchida; Saki Kimura; Mika Kanuka; Miho Morita; Michito Hamada; Satoru Takahashi; Yu Hayashi; Masashi Yanagisawa
Journal:  Elife       Date:  2016-12-30       Impact factor: 8.140

Review 9.  The Surviving Sepsis Campaign: research priorities for the administration, epidemiology, scoring and identification of sepsis.

Authors:  Mark E Nunnally; Ricard Ferrer; Greg S Martin; Ignacio Martin-Loeches; Flavia R Machado; Daniel De Backer; Craig M Coopersmith; Clifford S Deutschman
Journal:  Intensive Care Med Exp       Date:  2021-07-02

10.  Cortisol Response to Low-dose (1 µg) ACTH Stimulation for the Prediction of Outcome in Patients with Systemic Inflammatory Response Syndrome.

Authors:  Jelica Bjekić-Macut; Vojislav Radosavljević; Zoran Andrić; Dušan Ilić; Olivera Stanojlović; Danijela Vojnović Milutinović; Ivana Božić Antić; Marija Zdravković; Saša Hinić; Djuro Macut; Miloš Žarković
Journal:  J Med Biochem       Date:  2016-11-02       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.